Showing results (1141-1150 of 1,875) with videos related to
Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|May 29, 2012
cAMP regulation of airway smooth muscle functionCharlotte K Billington, Oluwaseun O Ojo, Raymond B Penn, et al.Pulmonary Pharmacology & Therapeutics|May 29, 2012
Cigarette smoke-induced inflammation and respiratory host defense: Insights from animal modelsJake K Nikota, Martin R StämpfliPulmonary Pharmacology & Therapeutics|May 22, 2012
Effects of obesity and weight loss on airway physiology and inflammation in asthmaOlga Sideleva, Kendall Black, Anne E DixonPulmonary Pharmacology & Therapeutics|August 13, 2013
Inhalable DNase I microparticles engineered with biologically active excipientsRihab Osman, Khuloud T Al Jamal, Pei-Lee Kan, et al.Pulmonary Pharmacology & Therapeutics|April 26, 2011
Mechanical failure, stress redistribution, elastase activity and binding site availability on elastin during the progression of emphysemaBéla Suki, Rajiv Jesudason, Susumu Sato, et al.Pulmonary Pharmacology & Therapeutics|July 7, 2011
Statins and outcome after hospitalization for COPD exacerbation: a prospective studyKonstantinos Bartziokas, Andriana I Papaioannou, Markos Minas, et al.Pulmonary Pharmacology & Therapeutics|October 4, 2011
YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in miceJin Won Huh, Sun-Yong Kim, Ji Hyun Lee, et al.Pulmonary Pharmacology & Therapeutics|October 11, 2011
Commonalities between the pro-fibrotic mechanisms in COPD and IPFLynne A MurrayPulmonary Pharmacology & Therapeutics|October 26, 2011
Bleomycin induced lung fibrosis increases work of breathing in the mouseJonathan E Phillips, Ruoqi Peng, Lisa Burns, et al.Pulmonary Pharmacology & Therapeutics|February 7, 2012
Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: a randomised controlled trialRonald Dahl, Ingrid Titlestad, Ari Lindqvist, et al.Pageof 188